Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme

被引:0
|
作者
Megan Mantica
Jan Drappatz
Frank Lieberman
Constantinos G. Hadjipanayis
L. Dade Lunsford
Ajay Niranjan
机构
[1] University of Pittsburgh Medical Center,
[2] University of Pittsburgh Medical Center,undefined
来源
Journal of Neuro-Oncology | 2023年 / 164卷
关键词
Stereotactic Radiosurgery; Bevacizumab; High-grade Glioma; Glioblastoma; Spectroscopy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:179 / 190
页数:11
相关论文
共 50 条
  • [1] Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme
    Mantica, Megan
    Drappatz, Jan
    Lieberman, Frank
    Hadjipanayis, Constantinos G. G.
    Lunsford, L. Dade
    Niranjan, Ajay
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (1) : 179 - 190
  • [2] Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme.
    Mantica, Megan
    Drappatz, Jan
    Lunsford, L. Dade
    Lieberman, Frank S.
    Niranjan, Ajay
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Stereotactic Radiosurgery and Bevacizumab for Recurrent Glioblastoma Multiforme
    Cabrera, Alvin R.
    Cuneo, Kyle C.
    Vredenburgh, James J.
    Sampson, John H.
    Kirkpatrick, John P.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (06): : 695 - 699
  • [4] Phase II study of bevacizumab and erlotinib in patients with recurrent glioblastoma multiforme
    Sathornsumetee, S.
    Vredenburgh, J. J.
    Rich, J. N.
    Desjardins, A.
    Quinn, J. A.
    Mathe, A. E.
    Gururangan, S.
    Friedman, A. H.
    Friedman, H. S.
    Reardon, D. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] PHASE II STUDY OF BEVACIZUMAB AND ERLOTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
    Reardon, David A.
    Sathornsumetee, Sith
    Vredenburgh, James J.
    Rich, Jeremy N.
    Desjardins, Annick
    Quinn, Jennifer A.
    Mathe, Alyssa
    Gururangan, Sridharan
    Friedman, Allen H.
    Friedman, Henry S.
    [J]. NEURO-ONCOLOGY, 2009, 11 (02) : 231 - 231
  • [6] Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma
    Jason P. Sheehan
    Georgios Mantziaris
    Adomas Bunevicius
    [J]. Journal of Neuro-Oncology, 2024, 167 : 231 - 232
  • [7] Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma
    Sheehan, Jason P.
    Mantziaris, Georgios
    Bunevicius, Adomas
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2024, 167 (01) : 229 - 230
  • [8] PHASE II STUDY OF BEVACIZUMAB AND TEMSIROLIMUS IN PATIENTS WITH PROGRESSIVE GLIOBLASTOMA MULTIFORME AFTER PRIOR BEVACIZUMAB TREATMENT
    Gaziel, Tine B.
    Soerensen, Morten
    Hasselbalch, Benedikte
    Poulsen, Hans Skovgaard
    Lassen, Ulrik
    [J]. NEURO-ONCOLOGY, 2010, 12 : 40 - 40
  • [9] PHASE I/II TRIAL OF RADIOSURGERY PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT/PROGRESSIVE GLIOBLASTOMA - INITIAL REPORT
    Mohammadi, Alireza Mohammad
    Chao, Samuel T.
    Peereboom, David M.
    Barnett, Gene H.
    Suh, John H.
    Brewer, Cathy
    Vogelbaum, Michael A.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 103 - 104
  • [10] Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case–control study
    Kyung-Jae Park
    Hideyuki Kano
    Aditya Iyer
    Xiaomin Liu
    Ajay Niranjan
    John C. Flickinger
    Frank S. Lieberman
    L. Dade Lunsford
    Douglas Kondziolka
    [J]. Journal of Neuro-Oncology, 2012, 107 : 323 - 333